Genome-wide enrichment screening reveals multiple targets and resistance genes for triclosan in Escherichia coli

Journal of Microbiology

Volumn 50, Issue 5, 2012, Pages 785-791

  Yu, Byung Jo ^a   Kim, Jung Ae ^a   Ju, Hyun Mok ^a   Choi, Soo Kyung ^a   Hwang, Seung Jin ^b   Park, Sungyoo ^b   Kim, EuiJoong ^c   Pan, Jae Gu ^a  

^a Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^b LG Household and Healthcare Ltd   (South Korea)

^c GenoFocus Inc   (South Korea)

Author keywords

E. coli; genomic library; multiple targets; resistance; triclosan

Indexed keywords

EID: 84868537120     PISSN: 12258873     EISSN: 19763794     Source Type: Journal    
DOI: 10.1007/s12275-012-2439-0     Document Type: Article

References (26)

1. Brötz-Oesterhelt, H. and Brunner, N. A. 2008. How many modes of action should an antibiotic have? Curr. Opin. Pharmacol. 8, 564-573.
2. Condell, O., Sheridan, Á., Power, K. A., Bonilla-Santiago, R., Sergeant, K., Renaut, J., Burgess, C., Fanning, S., and Nally, J. E. 2012. Comparative proteomic analysis of Salmonella tolerance to the biocide active agent triclosan. J. Proteomics75, 4505-4519.
3. Costa, C. S. and Antón, D. N. 2001. Role of the ftsa1p promoter in the resistance of mucoid mutants of Salmonella enterica to mecillinam: Characterization of a new type of mucoid mutant. FEMS Microbiol. Lett. 200, 201-205.
4. Gomez Escalada, M., Russell, A. D., Maillard, J. Y., and Ochs, D. 2005. Triclosan-bacteria interactions: Single or multiple target sites? Lett. Appl. Microbiol. 41, 476-481.
5. Hall, B. G. and Xu, L. 1992. Nucleotide sequence, function, activation, and evolution of the cryptic asc operon of Escherichia coli K12. Mol. Biol. Evol. 9, 688-706.
6. Heath, R. J. and Rock, C. O. 2000. Microbiology: A triclosan-resistant bacterial enzyme. Nature406, 145-146.
7. Heath, R. J., Rubin, J. R., Holland, D. R., Zhang, E., Snow, M. E., and Rock, C. O. 1999. Mechanism of triclosan inhibition of bacterial fatty acid synthesis. J. Biol. Chem. 274, 11110-11114.
8. Heath, R. J., Yu, Y. T., Shapiro, M. A., Olson, E., and Rock, C. O. 1998. Broad spectrum antimicrobial biocides target the fabI component of fatty acid synthesis. J. Biol. Chem. 273, 30316-30320.
9. Hirakawa, H., Nishino, K., Hirata, T., and Yamaguchi, A. 2003. Comprehensive studies of drug resistance mediated by overexpression of response regulators of two-component signal transduction systems in Escherichia coli. J. Bacteriol. 185, 1851-1856.
10. Jones, R. D., Jampani, H. B., Newman, J. L., and Lee, A. S. 2000. Triclosan: A review of effectiveness and safety in health care settings. Am. J. Infect. Control. 28, 184-196.
11. Kitagawa, M., Ara, T., Arifuzzaman, M., Ioka-Nakamichi, T., Inamoto, E., Toyonaga, H., and Mori, H. 2006. Complete set of ORF clones of Escherichia coli ASKA library (a complete set of E. coli K-12 ORF archive): Unique resources for biological research. DNA Res. 12, 291-299.
12. Lynch, M. D., Warnecke, T., and Gill, R. T. 2007. Scales: Multiscale analysis of library enrichment. Nat. Methods4, 87-93.
13. McMurry, L. M., Oethinger, M., and Levy, S. B. 1998a. Overexpression of marA, soxS, or acrAB produces resistance to triclosan in laboratory and clinical strains of Escherichia coli. FEMS Microbiol. Lett. 166, 305-309.
14. McMurry, L. M., Oethinger, M., and Levy, S. B. 1998b. Triclosan targets lipid synthesis. Nature394, 531-532.
15. Phan, T. N. and Marquis, R. E. 2006. Triclosan inhibition of membrane enzymes and glycolysis of Streptococcus mutans in suspensions and biofilms. Can. J. Microbiol. 52, 977-983.
16. Rahmati, S., Yang, S., Davidson, A. L., and Zechiedrich, E. L. 2002. Control of the acrAB multidrug efflux pump by quorum-sensing regulator sdiA. Mol. Microbiol. 43, 677-685.
17. Russell, A. D. 2004. Whither triclosan? J. Antimicrob. Chemother. 53, 693-695.
18. Saleh, S., Haddadin, R. N. S., Baillie, S., and Collier, P. J. 2011. Triclosan - an update. Lett. Appl. Microbiol. 52, 87-95.
19. Silver, L. L. 2007. Multi-targeting by monotherapeutic antibacterials. Nat. Rev. Drug Discov. 6, 41-55.
20. Villalain, J., Mateo, C. R., Aranda, F. J., Shapiro, S., and Micol, V. 2001. Membranotropic effects of the antibacterial agent triclosan. Arch. Biochem. Biophy. 390, 128-136.
21. von der Ohe, P. C., Schmitt-Jansen, M., Slobodnik, J., and Brack, W. 2012. Triclosan-the forgotten priority substance? Environ. Sci. Pollut. Res. 19, 585-591.
22. Webber, M. A., Coldham, N. G., Woodward, M. J., and Piddock, L. J. V. 2008. Proteomic analysis of triclosan resistance in Salmonella enterica serovar typhimurium. J. Antimicrob. Chemother. 62, 92-97.
23. Wei, Y., Vollmer, A. C., and LaRossa, R. A. 2001. In vivo titration of mitomycin c action by four Escherichia coli genomic regions on multicopy plasmids. J. Bacteriol. 183, 2259-2264.
24. White, S. W., Zheng, J., Zhang, Y. M., and Rock, C. O. 2005. The structural biology of type II fatty acid biosynthesis. Ann. Rev. Biochem. 74, 791-831.
25. Yazdankhah, S. P., Scheie, A. A., Høiby, E. A., Lunestad, B. T., Heir, E., Fotland, T.Ø., Naterstad, K., and Kruse, H. 2006. Triclosan and antimicrobial resistance in bacteria: An overview. Microb. Drug Resist. 12, 83-90.
26. Yu, B. J., Kim, J. A., and Pan, J. G. 2010. Signature gene expression profile of triclosan-resistant Escherichia coli. J. Antimicrob. Chemother. 65, 1171-1177.